|
|
A meta-analysis on the effect and safety of addition and reduction of Chaishao Liujunzi Decoction in the treatment of chronic gastritis |
GAO Gaiya1 XUE Jingdong2 BAI Yanyan1 LI Sha2 |
1.Department of Traditional Chinese Medicine, the First Clinical Medical College, Shaanxi University of Chinese Medicine, Shaanxi Province, Xianyang 712046, China;
2.Department of Hepatology, Shaanxi Hospital of Traditional Chinese Medicine, Shaanxi Province, Xi′an 710003, China |
|
|
Abstract Objective To analyze the efficacy and safety of addition and reduction of Chaishao Liujunzi Decoction in treating chronic gastritis by meta analysis. Methods Database of CNKI, VIP and Wanfang by computer was searched, the randomized controlled trial of the treatment of chronic gastritis with the method of subject word + free word was searched. Retrieved time was limited to September 2019. Meta analysis with Revman 5.3 software was used. Systematic evaluation of Chaishao Liujunzi Decoction in the treatment of chronic gastritis on total clinical efficiency, adverse reactions, recurrence rate, traditional Chinese medicine syndrome score, quality of life, pathological effect of gastric mucosa, anti Helicobacter pylori infection were carried out. Results Total of 15 studies, all in Chinese literature, included 1386 patients. Meta analysis results suggested that the addition and reduction of Chaishao Liujunzi Decoction could significantly improve total clinical efficiency of chronic gastritis [OR = 3.96, 95%CI (2.84-5.53), P < 0.000 01], reduce adverse reaction [OR = 0.28, 95%CI (0.10-0.77), P = 0.01], reduce recurrence rate [OR = 0.36, 95%CI (0.16-0.80), P = 0.01], alleviate traditional Chinese medicine syndrome score (P < 0.05), improve quality of life (P < 0.05), improve gastric mucosa atrophy [OR = 2.69, 95%CI (1.38-5.26), P = 0.004], improve intestinal metaplasia of gastric mucosa [OR = 3.19, 95%CI (1.32-7.70), P = 0.01], but improve dysplasia of gastric mucosa [OR = 2.12, 95%CI (0.97-4.67), P = 0.06] and the efficacy of anti Helicobacter pylori infection were not exact. Conclusion Addition and reduction of Chaishao Liujunzi Decoction can significantly improve clinical efficacy of chronic gastritis, but due to the limitation of the quality of the included studies, the above conclusions need to be verified by more high-quality randomized controlled trial.
|
|
|
|
|
[1] 张声生,唐旭东,黄穗平.慢性胃炎中医诊疗专家共识意见(2017年)[J].中华中医药杂志,2017,7(12):48-49.
[2] 夏楠楠,汶明琦.柴芍六君子汤治疗慢性胃炎50例临床观察[J].湖南中医杂志,2014,30(6):50-51.
[3] 黄雄星,常建国.柴平汤加减治疗慢性胃炎随机对照试验的meta分析[J].湖北中医杂志,2018,40(7):3-7.
[4] 刘勇,赵一丁,闫小宁.中药健脾法治疗特应性皮炎的meta分析[J].中国中药杂志,2018,43(9):1922-1933.
[5] Jadad AR,Moore RA,Carroll D. Assessing the quality of reports of randomized clinical trials:is blinding necessary? [J]. Control Clin Trials,1996,17:1-12.
[6] 康凤河.柴芍六君子汤治疗慢性糜烂性胃炎临床研究[J].中外健康文摘,2013,10(25):414-415.
[7] 李金华,周加林.肝郁脾虚型慢性萎缩性胃炎应用柴芍六君汤加减治疗的效果观察[J].大家健康,2017,11(7):77.
[8] 齐岭山.柴芍六君子汤治疗慢性糜烂性胃炎的临床观察[J].医药前沿,2014(4):232-233.
[9] 朱建斌.柴芍六君子汤治疗慢性糜烂性胃炎临床研究[J].医药前沿,2013(19):217-218.
[10] 李军,李振华.柴芍六君子汤加减治疗肝郁脾虚型慢性萎缩性胃炎的效果评价[J].特别健康,2017,24(1):268-269.
[11] 冀雯芳.柴芍六君子汤加减治疗肝郁脾虚型慢性萎缩性胃炎的效果观察[J].河南医学研究,2016,25(11):2002-2003.
[12] 刘晓棠,胡晓红.柴芍六君子汤加减治疗慢性胃炎的临床效果[J].内蒙古中医药,2017,11(21):73-74.
[13] 张安福,张景环,况斌.柴芍六君子汤加减治疗肝郁脾虚型慢性萎缩性胃炎的效果观察[J].世界最新医学信息文摘,2017,17(35):17-18.
[14] 曹建春.慢性胃炎应用柴芍六君子汤治疗的疗效观察[J].海峡药学,2013,3(25):193-194.
[15] 黄曜勇.柴芍六君子汤治疗慢性胃炎的随机平行对照研究[J].实用中医内科杂志,2013,10(27):26-27.
[16] 黄建东,李达芬.柴芍六君子汤治疗慢性糜烂性胃炎临床研究[J].中医学报,2012,12(27):1647-1648.
[17] 李莉,郑舜华,李刚.柴芍六君子汤治疗肝郁脾虚型慢性萎缩性胃炎临床观察[J].上海中医药杂志,2009,3(43):26-28.
[18] 邝宇香,黄穗平,张北平.柴芍六君子汤治疗肝郁脾虚型慢性胃炎45例[J].浙江中医药大学学报,2008,32(3):353-354.
[19] 徐正云,陈岩岩.柴芍六君子汤治疗肝郁脾虚型慢性萎缩性胃炎疗效观察[J].中医药临床杂志,2016,9(28):1296-1297.
[20] 靳光荣.柴芍六君子汤治疗肝郁脾虚型慢性萎缩性胃炎40例[J].中国中医药现代远程教育,2014,12(18):32-33. |
|
|
|